What can we help you with today?
🔗 CustomizeMedical Overview of Spondyloepimetaphyseal Dysplasia With Joint Laxity, Type 3
Sources citedA rare primary bone dysplasia characterized by multiple joint dislocations, in particular in hips and knees present at birth, but the elbows, wrists, ankles, and patellae can also be affected; severe joint laxity, scoliosis, slender fingers with distal tapering, and growth deficiency developing in the post-natal period resulting in short stature. Gracile metacarpals and metatarsals, delayed bone age with poorly ossified carpal and tarsal bones, metaphyseal and epiphyseal dysplasia, slender ribs, and spondylar dysplasia are radiographical signs. Intelligence is usually normal.
Classification & codes: GARD 0016348 · Orphanet ORPHA:642085 · OMIM 618395 · ICD-10 Q77.7
Sources: GARD (NIH/NCATS), Orphanet · last reviewed 2026. Educational only — not medical advice.
News & Updates
ALYFTREK shows positive Phase 3 results in children ages 2–5
Vertex plans global regulatory submissions for this pediatric age group in the first half of 2026.
Airway clearance routines that actually work for teens
3 open trials match this profile
Locations in NC, FL and GA.
Spondyloepimetaphyseal Dysplasia With Joint Laxity, Type 3 Family Conference
Illustrative example event · location TBD
Care & management overview — Spondyloepimetaphyseal Dysplasia With Joint Laxity, Type 3
Educational programming; see the cited sources on this hub.
Spondyloepimetaphyseal Dysplasia With Joint Laxity, Type 3 News & Developments
The latest Spondyloepimetaphyseal Dysplasia With Joint Laxity, Type 3 research, news and registered trials — live from public sources. Each link opens the source directly; nothing here is auto-summarized or invented.
Recruiting trials
View all →Find a Spondyloepimetaphyseal Dysplasia With Joint Laxity, Type 3 Specialist Near You
Sample results — illustrative only. A real version would search the NPPES provider registry and CFF-certified centers by actual distance from your ZIP.
Treatment & Daily Living
Medical care plus the everyday therapies and supports relevant to Spondyloepimetaphyseal Dysplasia With Joint Laxity, Type 3. Treatment is individualized — ask your specialist about the medications, procedures and therapies. Browse medications →
Media Center
News, podcasts, books & research for Spondyloepimetaphyseal Dysplasia With Joint Laxity, Type 3 — real coverage, links out, never re-hosted.
Audience Guides
Plain-language guidance for the people around someone with Spondyloepimetaphyseal Dysplasia With Joint Laxity, Type 3 — how to understand it and talk about it. AI-generated for communication, not medical advice; always confirm specifics with a clinician.
Companies Developing Treatments
Biopharma companies with registered trials for Spondyloepimetaphyseal Dysplasia With Joint Laxity, Type 3 — from ClinicalTrials.gov. Informational, not an endorsement, and not every program is in trials.
Preferences only — saved to your account, never shared or sold. No PHI. Sources: GARD (NIH/NCATS), Orphanet.
Tools
Every institution behind the faculty, with their affiliated experts.
Plain-language tools
For clinicians, nonprofits & industry partners.
Translates any dense medical text — papers, lab results, visit notes, jargon — into plain language.
Live on tomekohealth.com — not a demo mock-up.
Research Collaboration & Matching
Live on tomekohealth.com — not a demo mock-up.
Mental Health Toolkit
Sources citedCoping strategies, how to find a a specialist therapist, and mental-health resources built for the ups and downs of living with Spondyloepimetaphyseal Dysplasia With Joint Laxity, Type 3 — for patients and caregivers alike.
Preferences only — saved to your account, never shared or sold. No PHI. Sources: GARD (NIH/NCATS), Orphanet.
Grand Rounds & Accredited Education
Open Questions
Ask the community →Anyone can ask. Sign in to answer. Peer support — not medical advice, and no PHI.
Survey
Reflect on how you are doing — anonymous, with only de-identified group averages shown.
Community & Support Groups
For people living with Spondyloepimetaphyseal Dysplasia With Joint Laxity, Type 3. Peer support, not medical advice; no PHI.
For caregivers and family navigating Spondyloepimetaphyseal Dysplasia With Joint Laxity, Type 3.
Recent From the Community
Certified Centers of Excellence
CFF networkCare centers and specialists for Spondyloepimetaphyseal Dysplasia With Joint Laxity, Type 3, from Tomeko’s verified provider directory (CMS NPPES).
Representative CFF centers — the official CFF directory has the complete, current list.
Nonprofits & Foundations
Grants & Financial Help
Representative programs — illustrative only. Eligibility and availability vary; not a guarantee of assistance.
Patient & Family Guides
Sources citedAn annual snapshot of Spondyloepimetaphyseal Dysplasia With Joint Laxity, Type 3 research, treatment access and outcomes, written in plain language for patients and families.
Practical starting points and things to plan for in the first year after diagnosis.
Step-by-step guidance, what to expect, and a sample daily routine.
Disclosure, accommodations, insurance transitions and workplace planning for teens and young adults with Spondyloepimetaphyseal Dysplasia With Joint Laxity, Type 3.
Sources: GARD (NIH/NCATS), Orphanet · last reviewed 2026. Educational only — not medical advice.